Literature DB >> 2839549

Expression of novel interleukin 2 binding molecules and their functional roles in human B cell differentiation.

T Tanaka1, O Saiki, S Doi, M Suemura, S Negoro, S Kishimoto.   

Abstract

Expressions and functional roles of novel IL-2 binding molecules (p70, 75) in the differentiation of B cells into Ig secreting cells were explored by using human several B cell lines and tonsillar B cells. Affinity-crosslinking studies revealed that five of nine B cell lines expressed p70 and p75 without detectable Tac antigen (p55) expression and the expression was associated with B cell maturation. In tonsillar B cells, small high-density B cells did not express p70 and p75, whereas large low-density B cells, which were thought to be activated in vivo, expressed them. Binding assays of radiolabeled IL-2 showed that the affinity of these molecules was intermediate (kD = 1-3 nM, 700-3,000 sites/cell). Furthermore, high concentrations of IL-2 (greater than 100 U/ml) induced Ig productions in large B cells and two of five cell lines. These results taken together suggest that B cells may express novel IL-2 binding molecules, associated with B cell differentiation and differentiate into Ig secreting cells by IL-2 through novel IL-2 binding molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839549      PMCID: PMC303511          DOI: 10.1172/JCI113589

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Long term culture of tumour-specific cytotoxic T cells.

Authors:  S Gillis; K A Smith
Journal:  Nature       Date:  1977-07-14       Impact factor: 49.962

2.  Interleukin 2 functions through novel interleukin 2 binding molecules in T cells.

Authors:  T Tanaka; O Saiki; S Doi; S Negoro; S Kishimoto
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

3.  Demonstration of a non-Tac peptide that binds interleukin 2: a potential participant in a multichain interleukin 2 receptor complex.

Authors:  M Tsudo; R W Kozak; C K Goldman; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  A highly sensitive enzyme-linked immunosorbent assay for human immunoglobulin E: comparison of microtiter plate and disk methodologies.

Authors:  P K Goldsmith
Journal:  Anal Biochem       Date:  1981-10       Impact factor: 3.365

6.  Stimulation of immunoglobulin secretion in human B lymphocytes as a direct effect of high concentrations of IL 2.

Authors:  P Ralph; G Jeong; K Welte; R Mertelsmann; H Rabin; L E Henderson; L M Souza; T C Boone; R J Robb
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

7.  Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells.

Authors:  M C Mingari; F Gerosa; G Carra; R S Accolla; A Moretta; R H Zubler; T A Waldmann; L Moretta
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

8.  Expression of Tac antigen on activated normal human B cells.

Authors:  M Tsudo; T Uchiyama; H Uchino
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

9.  Expression of interleukin 2 receptors on activated human B cells.

Authors:  T A Waldmann; C K Goldman; R J Robb; J M Depper; W J Leonard; S O Sharrow; K F Bongiovanni; S J Korsmeyer; W C Greene
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

10.  Activated B cells express receptors for, and proliferate in response to, pure interleukin 2.

Authors:  R H Zubler; J W Lowenthal; F Erard; N Hashimoto; R Devos; H R MacDonald
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

View more
  1 in total

1.  Interleukin 2-regulated in vitro antibody production following a single spinal manipulative treatment in normal subjects.

Authors:  Julita A Teodorczyk-Injeyan; Marion McGregor; Richard Ruegg; H Stephen Injeyan
Journal:  Chiropr Osteopat       Date:  2010-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.